Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHansard Regulatory News (HSD)

Share Price Information for Hansard (HSD)

Share Price is delayed by 15 minutes
Get Live Data
54.00    0.75 (1.41%)
Bid:
52.50
Ask:
54.50
Spread: 2.00 (3.81%)
Market Cap: £73.73m
HSD Live PriceLast checked at - London Stock Exchange

Intraday Hansard Share Chart

Over-Allotment Option

15 Dec 2006 14:31

Hansard Global plc15 December 2006 This announcement and the information contained herein is not for publication, distribution or release, in whole or in part, in, or into, directly or indirectly, the United States, Australia, Canada and Japan or any other jurisdiction where such publication, distribution or release would be unlawful. 15 December 2006 HANSARD GLOBAL PLC Announcement of Exercise of Over-Allotment Option Hansard Global plc ("Hansard" or the "Company"), the specialist long-term savings provider, announces that, in connection with the offer of ordinary shares in the capital of the Company (the "Ordinary Shares") to institutional investors and management (the "Offer") announced on 13 December 2006, Panmure Gordon (UK) Limited ("Panmure Gordon"), as stabilising manager, has exercised in full the over-allotment option in respect of 7,600,699 existing Ordinary Shares granted to it by Polar Cap Limited (the "Selling Shareholder"). The Selling Shareholder will receive £19.8 million gross proceeds arising from the exercise of the over-allotment option. Including the exercise of the over-allotment option, the total size of the Offer becomes £151.5 million (58,272,025 Ordinary Shares), representing approximately 42.5% of the issued ordinary share capital of the Company at 15 December 2006. Excluding the 5,368,529 Ordinary Shares acquired by management in the Offer, Hansard has a free float of 52,903,496 Ordinary Shares or 38.5% of the issued ordinary share capital of the Company as at 15 December 2006. Important Information The contents of this announcement have been prepared by and are the soleresponsibility of the Company. Panmure Gordon is regulated in the United Kingdom by the Financial ServicesAuthority and is acting for the Company, the Selling Shareholder and Dr. LeonardPolonsky and no one else in connection with the Offer and Admission and will notregard any other person (whether or not a recipient of this announcement) astheir client, nor will they be responsible to anyone other than the Company, theSelling Shareholder or Dr. Leonard Polonsky for providing the protections afforded to the clients of Panmure Gordon, nor for providing advice in relation to theOffer, the contents of this announcement or any transaction, arrangement orother matter referred to herein. This announcement is for information purposes only and does not constitute anoffer to sell or the solicitation of an offer to buy securities of the Companyin any jurisdiction in which such offer, solicitation or sale would be unlawfulprior to registration, exemption from registration or qualification under thesecurities law of any such jurisdiction. This announcement and the offer of the securities to which it relates are directed only at persons outside the United Kingdom and persons in the United Kingdomwho have professional experience in matters related to investments or who arehigh net worth persons within article 12(5) of the Financial Services andMarkets Act 2000 (Financial Promotion) Order 2001 and must not be acted on orrelied on by other persons in the United Kingdom. In addition, if and to the extent that this announcement is communicated in, orthe offer of the securities to which it relates is made in, any EEA Member Statethat has implemented Directive 2003/71/EC (together with any applicableimplementing measures in any Member State, the "Prospectus Directive") beforethe publication of a prospectus in relation to the securities which has beenapproved by the competent authority in that Member State in accordance with theProspectus Directive (or which has been approved by a competent authority inanother Member State and notified to the competent authority in that MemberState in accordance with the Prospectus Directive), this announcement and theoffer are only addressed to and directed at persons in that Member State who arequalified investors within the meaning of the Prospectus Directive (or who areother persons to whom the offer may lawfully be addressed) and must not be actedon or relied on by other persons in that Member State. This announcement and the information contained herein is not for publication,distribution or release in, or into, directly or indirectly, the United States,Australia, Canada or Japan and does not constitute, or form part of, an offer ofthe securities for sale in or into the United States, Australia, Canada orJapan. The Offer and the distribution of this announcement may be restricted bylaw in certain jurisdictions and persons into whose possession any document orother information referred to herein comes should inform themselves about andobserve any such restriction. Any failure to comply with these restrictions mayconstitute a violation of the securities laws of any such jurisdiction. The securities referred to in this document have not been registered under theU.S. Securities Act of 1933, as amended (the "Securities Act") and may not beoffered or sold in the United States absent registration or an exemption fromthe registration requirements of the Securities Act. The Company does notpresently intend to offer publicly any securities in the United States or toregister any securities under the Securities Act. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
20th Mar 20263:21 pmRNSInsurance Recovery Received
5th Mar 20267:00 amRNSInterim Results
5th Nov 202511:29 amRNSResult of AGM
29th Oct 20257:00 amRNSHolding(s) in Company
2nd Oct 20258:48 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSResults for the year ended 30 June 2025
24th Jul 20257:00 amRNSDirectorate Change
17th Mar 20257:00 amRNSDr Leonard Polonsky
6th Mar 20257:00 amRNSInterim Result
17th Dec 20247:00 amRNSDirectorate Change
28th Nov 20247:00 amRNSDirectorate Change
13th Nov 202412:00 pmRNSResult of AGM
22nd Oct 20247:00 amRNSBlock listing Interim Review
2nd Oct 20247:00 amRNSAppointment of Chief Financial Officer
26th Sep 20247:00 amRNSResults for the year ended 30 June 2024
24th Sep 20247:00 amRNSDirectorate Change
2nd Aug 20247:00 amRNSDirectorate Change
1st Jul 20248:46 amRNSTR-1 Notification of Major Holdings
27th Jun 20247:00 amRNSDistribution Agreement
22nd Apr 20249:36 amRNSBlock listing Interim Review
7th Mar 20247:05 amRNSResults for the six months ended 31 December 2023
15th Feb 20247:00 amRNSDirectorate Change
8th Nov 202311:55 amRNSResult of AGM
23rd Oct 20237:24 amRNSBlock listing Interim Review
28th Sep 202311:42 amRNSResults for the year ended 30 June 2023
28th Sep 20237:00 amRNSResults for the year ended 30 June 2023
27th Jul 20237:00 amRNSNew business results for the year ended 30/06/2023
23rd May 20239:27 amRNSDirector/PDMR Shareholding
4th May 20237:00 amRNSTrading Statement
20th Apr 20233:01 pmRNSBlock listing Interim Review
9th Mar 20237:00 amRNSResults for the six months ended 31 December 2022
26th Jan 20237:00 amRNSNew business results for 6 months ended 31/12/22
23rd Jan 20237:00 amRNSDirectorate Change
23rd Nov 20227:00 amRNSDirectorate Change
3rd Nov 20227:00 amRNSTrading update for the quarter ended 30/09/2022
2nd Nov 202212:22 pmRNSResult of AGM
25th Oct 20224:41 pmRNSSecond Price Monitoring Extn
25th Oct 20224:36 pmRNSPrice Monitoring Extension
20th Oct 202211:18 amRNSBlock listing Interim Review
5th Oct 20224:36 pmRNSPrice Monitoring Extension
26th Sep 20224:41 pmRNSSecond Price Monitoring Extn
26th Sep 20224:36 pmRNSPrice Monitoring Extension
22nd Sep 20227:00 amRNSResults for the year ended 30 June 2022
21st Jul 20227:00 amRNSNew business results for the year ended 30/06/2022
20th May 202211:59 amRNSPDMR Shareholding
5th May 20227:00 amRNSTrading update for the period ended 31 March 2022
22nd Apr 20228:30 amRNSBlock listing Interim Review
25th Mar 20229:54 amRNSListing Rule 9.6.14(R) Disclosure
3rd Mar 20227:05 amRNSAppointment of Chairman
3rd Mar 20227:00 amRNSResults for the six months ended 31 December 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.